Stocks on Pace to Break Losing Streak Despite Big Boeing Losses

FAANG stock Apple was upgraded to "buy"

Managing Editor
Mar 11, 2019 at 11:59 AM
facebook twitter linkedin


Stocks are higher this afternoon, with the Dow Jones Industrial Average (DJI) in the black despite major losses for Boeing (BA) stock. Bolstering the index is FAANG stock Apple (AAPL), which is up more than 3% after a fresh "buy" rating. Meanwhile, the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are also comfortably higher at midday. With a push from this morning's impressive retail sales data, all three indexes are set to break their recent five-day losing streak.

Continue reading for more on today's market, including:

  • Stocks haven't done this since Trump was elected.
  • Schaeffer's Senior V.P. of Research Todd Salamone took to CNBC to explain how Fed remarks could aid the S&P 500.
  • Plus, puts surge on Men's Warehouse parent; the Wall Street Journal's latest victim; and the Nasdaq's top performer.

Midday Market Stats March 11

Puts are popping for Tailored Brands Inc (NYSE:TLRD), with 17,000 traded so far today. The volume is 66 times the expected intraday pace, with the March 13 put leading the way by a long shot. This bearish surge comes just ahead of the company's quarterly report, expected after the close on Wednesday, March 13. TLRD stock has suffered several bear gaps peaking around $36 in May, and is down 49% year-over-year. At last glance, the stock is up 0.6% at $11.83.

Care.com Inc (NYSE:CRCM) is at the bottom of the New York Stock Exchange (NYSE) and has gapped 15% lower trade at $19.64, after a critical Wall Street Journal article stated the company (on multiple occasions) has falsely reported care providers as being state-licensed. CRCM has now fallen more than 21% this month, and is back below the $20 level since for the first time since early January.

Daily CRCM Since March 2018

The top stock on the Nasdaq today is Seres Therapeutics Inc (NASDAQ:MCRB),after the company announced its collaboration with AstraZeneca (AZN) to research cancer therapy drugs. MCRB is up 45% at $7.42, at last check, bringing its year-to-date lift to an impressive 75%.

JUST RELEASED: The Complete Guide to Earnings Season Profits

earn21cover"/>

 




 
Special Offers from Schaeffer's Trading Partners